InnoVenture ue
  • EN
  • PL
InnoVenture
  • How we invest
  • Portfolio
  • News
  • Blog
  • Contact
  • EN
  • PL
  • FB
  • TW
  • IN
  • ue

News

TRIGON and PAAN Capital invest in Poltreg

New investors to finance up-scaling and laboratory

The NCBR chose us in its latest competition

Thanks to BRIdge Alfa we will support R&D projects with PLN 30 millions

We are cooperating with the Jagiellonian University

Contract with Technology Transfer Center of the Jagiellonian University - CITTRU

Alfa School in the Krakow Technology Park

An opportunity to learn about the offer of private investors

Cooperation with the Cracow University of Technology

Cooperation agreement with INTECH PK

We are moving

We invite you to our new, modern office

INNOventure and SPIN-US together for the business and science sector

We are starting our cooperation with University of Silesia

We invest in Poltreg - a company that commercializes an innovative method of diabetes treatment

12/20/2015 INNOventure has invested in the Gdansk-based Poltreg company, which develops and commercializes...

Contract with AGH special purpose entity

INNOventure signed a contract with Krakowskie Centrum Innowacyjnych Technologii INNOAGH

We give our recognition to young scientists

We took part in Krakow Conference of Young Scientists

INNOventure, together with NCBR, supports the commercialization of research at Polish universities

Looking for R&D ready to be launched to market

We are investing in a company that develops a drug for leukemia

Dendrimers - potentially a cure for chronic lymphocytic leukemia

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
InnoVenture

INNOventure ASI Sp. z o.o.

z siedzibą w Krakowie

NIP: 675-151-34-01

Podole 60, 30-394 Kraków

tel. +48 123 878 160

office@innoventure.vc

Company registered in Sąd Rejonowy dla Krakowa-Śródmieścia w Krakowie, XI Wydział Gospodarczy Krajowego Rejestru Sądowego (District Court for Kraków-Śródmieście in Kraków, 11th Department of Commerce of the National Court Register). Initial capital 25.759,00 zł. KRS (National Court Register) number: 0000540389.

  • BRIdge Alfa Grant Project
  • BRIdge Alfabet
  • How we invest
  • Portfolio
  • News
  • Blog